Distribution began January 30, 2026. Unredeemed electronic payments were converted to paper checks mailed March 3, 2026.
StatusPayments DistributedSee the current-status update above.
Claim DeadlineSeptember 18, 2025New claims are not currently accepted.
Settlement Fund$1 millionApproved deductions and allocation terms may apply.
Potential BenefitPurchase-based cash paymentEligibility and payment terms apply.
What Happened?
The lawsuit alleged that CVS sold recalled eye-drop products that were defective or not worth the purchase price. CVS denied that the products were defective and denied wrongdoing and liability.
Who Was Covered?
The class covered U.S. purchasers of specified recalled CVS Health eye-drop products from October 1, 2021 through October 25, 2023.
What Benefits Were Available?
Claims with proof were eligible for time-adjusted reimbursement of qualifying purchases. Claims without proof were paid pro rata for up to three qualifying purchases, subject to the settlement terms.
Claims and Payment Information
Distribution began January 30, 2026. Unredeemed electronic payments were converted to paper checks mailed March 3, 2026. People with an existing claim or notice should rely on claim-specific communications and the official source.
• Claim deadline: September 18, 2025 • Distribution began: January 30, 2026 • Replacement checks mailed: March 3, 2026
Settlement Fund and Legal Fees
Administration, legal fees, expenses, benefit payments, and other approved deductions are governed by the official documents and court orders and can affect individual benefits.
Case Information
Ruffin v. CVS Pharmacy, Inc. 7:23-cv-01660-BO-RN U.S. District Court for the Eastern District of North Carolina.